Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects
Authors:
- 1 September 1981
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 74 (4) , 306-309
Abstract
Thirteen acute psychotic patients received continuous oral treatment with perphenazine for a period of 8 weeks. Blood samples for quantification of perphenazine, perphenazine sulphoxide and prolactin were drawn twice weekly. Simultaneously, the therapeutic outcome and the degree of extrapyramidal side effects were recorded. The following conclusions were made: 1. In accordance with results achieved in one of our earlier investigations, a high risk of provoking extrapyramidal side effects was associated with plasma levels of perphenazine exceeding about 3 nmol/l. 2. An excellent therapeutic outcome was associated with plasma concentrations of perphenazine above 1.5 nmol/l. 3. Plasma concentrations of perphenazine and prolactin were poorly correlated to each other (R=0.49). 4. A significant correlation (R=0.85) was shown between the scores for the Brief Psychiatric Rating Scale and the Comprehensive Psychopathological Rating Scale.Keywords
This publication has 17 references indexed in Scilit:
- Clinical Significance of Plasma Drug and Prolactin Levels During Acute Chlorpromazine Treatment: A Replication StudyThe British Journal of Psychiatry, 1979
- Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs.British Journal of Clinical Pharmacology, 1979
- A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALEActa Psychiatrica Scandinavica, 1978
- Radioimmunoassay for fluphenazine in human plasma.British Journal of Clinical Pharmacology, 1978
- Plasma Level Monitoring of Antipsychotic DrugsClinical Pharmacokinetics, 1978
- Homologous radioimmunoassay for human prolactinInternational Journal of Nuclear Medicine and Biology, 1976
- Determination of perphenazine and itssulphoxide metabolite olite in human plasma after therapeutic doses by gas chromatographyJournal of Chromatography A, 1975
- THE RELATIONSHIP OF PLASMA CHLORPROMAZINE TO ITS 7‐HYDROXY AND SULPHOXIDE METABOLITES IN A LARGE POPULATION OF CHRONIC SCHIZOPHRENICSBritish Journal of Clinical Pharmacology, 1974
- Determination of Thioxanthenes in Plasma at Therapeutic ConcentrationsActa Pharmacologica et Toxicologica, 1971
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970